AEterna Zentaris Inc. (NASDAQ: AEZS) today announced the initiation, by its partner Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), of a Phase ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE